Salicylic Acid

Manufacturer
Trinity Pharmaceuticals, LLC
Effective date
2023-03-22
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:47:55

Label at a glance#

ProductSalicylic Acid
Active ingredientSALICYLIC ACID
Label structure3 sections

Label contents#

Full prescribing information#

SPL PATIENT PACKAGE INSERT SECTION

SPL UNCLASSIFIED SECTION

Rx only

FOR DERMATOLOGICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

DESCRIPTION

DESCRIPTION SECTION

Salicylic Acid, 27.5% is a topical preparation containing 27.5% Salicylic Acid in a film-forming vehicle composed of: acrylates copolymer, isopropyl alcohol, isobutyrate, n-butyl acetate, and polyvinyl butyrate. The pharmacologic activity of this medication is generally attributed to the keratolytic activity of salicylic acid which is incorporated into a film-forming vehicle designed to cover the wart without the need for a bandage. The chemical structural formula of salicylic acid is:

chemical structure
chemical structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Although the exact mode of action for salicylic acid in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses.

INDICATIONS AND USES

INDICATIONS & USAGE SECTION

Salicylic Acid, 27.5% is indicated for the topical treatment and removal of common warts and plantar warts.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Salicylic Acid, 27.5% should not be used by diabetics or patients with impaired blood circulation. Salicylic Acid, 27.5% should not be used on moles, birthmarks, unusual warts with hair growing from them or warts on the face.

PRECAUTIONS

GENERAL PRECAUTIONS SECTION

Salicylic Acid, 27.5% is for external use only. Do not permit Salicylic Acid, 27.5% to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. Salicylic Acid, 27.5% should not be allowed to contact normal skin surrounding the wart. Treatment should be discontinued if excessive irritation occurs. Salicylic Acid, 27.5% is flammable and should be kept away from fire or flame.  Keep bottle tightly capped when not in use.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

A localized irritant reaction may occur if Salicylic Acid, 27.5% is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Prior to application of Salicylic Acid, 27.5% soak wart in warm water for five minutes. Remove any loosened tissue by gently rubbing with a brush, wash cloth, emery board or pumice stone. Dry thoroughly. Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second. Treatment should be once or twice a day and should continue as directed by physician. Be careful not to apply to surrounding skin.  Clinically visible improvement will normally occur during the first or second week of therapy. Maximum resolution may be expected after four to six weeks of drug use.

HOW SUPPLIED

HOW SUPPLIED SECTION

Salicylic Acid, 27.5% is supplied in 10 mL amber glass bottles with brush applicator - NDC 54295-304-11.

Store at 20ºC to 25ºC (68ºF to 77ºF)., excursions permitted between 15ºC and 30ºC (between 59ºF and 86ºF). Brief exposure to temperatures up to 40ºC (104ºF) may be tolerated provided the mean kinetic temperature does not exceed 25ºC (77ºF); however, such exposure should be minimized. Protect from freezing.

SPL UNCLASSIFIED SECTION

KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.

Marketed By:
Trinity Pharmaceuticals LLC
1 International Plaza, Suite 550
Philadelphia, PA 19113
TrinityPharmaLLC.com
REV 11/13

Salicylic Acid, 27.5% 10 mL Container Label Principal Display Panel Text:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54295-304-11

Rx only

For topical use only
Not for ophthalmic use

Salicylic Acid, 27.5%
10 mL

Salicylic Acid, 27.5% carton Label
Salicylic Acid, 27.5% carton Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1095689salicylic acid 27.5 % Topical SolutionPSN2
1095689salicylic acid 275 MG/ML Topical SolutionSCD2
1095689salicylic acid 27.5 % Topical SolutionSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54295-304-112023-03-22C16284748780-19855e2a2-4914-60a7-e053-dbdaa90a05bdSalicylic Acid, 27.5%
54295-304-112019-11-27C16284748780-19855e2a2-4914-60a7-e053-dbdaa90a05bdSalicylic Acid, 27.5%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54295-304-11Salicylic Acid1 in 1 CARTONSOLUTION12
54295-304-11Salicylic Acid10 mL in 1 BOTTLE, WITH APPLICATORSOLUTION102

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54295-304SALICYLIC ACID SOLUTION [TRINITY PHARMACEUTICALS, LLC]2Legacy NDC, 2 package rows20230323_31c49cc7-e324-44c7-bd26-2d2344c34a40.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54295-304-11ML - Milliliter54295-304300cb2c4-8510-4171-b81b-7c14184425c912014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
salicylic acidACTIVE INGREDIENTO414PZ4LPZ1
salicylic acidACTIVE MOIETYO414PZ4LPZ1
BUTYL ACETATEINACTIVE INGREDIENT464P5N19051
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M4163021

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54295-30454295-304-11

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 9 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302LOTION, AUGMENTED / TOPICAL2070 mgExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302SOLUTION / TOPICAL40 %w/vExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302OIL / TOPICAL72 mgExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302GEL / TOPICAL75 mgExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302TABLET, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302GEL, METERED / TOPICAL525 mgExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302SWAB / TOPICAL43.9 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302OIL / AURICULAR (OTIC)6 mgExact identifier — unii candidate
9 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302SPONGE / TOPICAL4 %w/wExact identifier — unii candidate
9 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f7816e8e-23ed-7375-e053-6294a90a78c631c49cc7-e324-44c7-bd26-2d2344c34a402023-03-22Adverse reactionsExact identifier
spl id: f7816e8e-23ed-7375-e053-6294a90a78c6
spl set id: 31c49cc7-e324-44c7-bd26-2d2344c34a40

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.